Skip to Main Content
Back to News

Insider Sale: Chief Financial Officer of $RARE Sells 7,942 Shares

Automated

Howard Horn, the Chief Financial Officer of $RARE, sold 7,942 shares of the company on 10-13-2025 for an estimated $250,252. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.5% of their shares of this class of stock. Following this trade, they now own 98,227 shares of this class of $RARE stock.

$RARE Insider Trading Activity

RARE Insider Trades

$RARE insiders have traded $RARE stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $RARE stock by insiders over the last 6 months:

  • HOWARD HORN (Chief Financial Officer) sold 7,942 shares for an estimated $250,252
  • CORAZON (CORSEE) D. SANDERS sold 2,405 shares for an estimated $89,922
  • KARAH HERDMAN PARSCHAUER (EVP and Chief Legal Officer) sold 2,450 shares for an estimated $76,366
  • ERIC CROMBEZ (EVP and Chief Medical Officer) has made 0 purchases and 2 sales selling 762 shares for an estimated $28,901.
  • THEODORE ALAN HUIZENGA (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 148 shares for an estimated $4,503.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RARE Hedge Fund Activity

We have seen 164 institutional investors add shares of $RARE stock to their portfolio, and 148 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RARE Congressional Stock Trading

Members of Congress have traded $RARE stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $RARE stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$RARE Analyst Ratings

Wall Street analysts have issued reports on $RARE in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 09/09/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 09/05/2025
  • Canaccord Genuity issued a "Buy" rating on 08/08/2025
  • Morgan Stanley issued a "Overweight" rating on 07/14/2025
  • Guggenheim issued a "Buy" rating on 06/20/2025
  • William Blair issued a "Outperform" rating on 05/28/2025

To track analyst ratings and price targets for $RARE, check out Quiver Quantitative's $RARE forecast page.

$RARE Price Targets

Multiple analysts have issued price targets for $RARE recently. We have seen 8 analysts offer price targets for $RARE in the last 6 months, with a median target of $65.0.

Here are some recent targets:

  • Raghuram Selvaraju from HC Wainwright & Co. set a target price of $80.0 on 09/09/2025
  • Kristen Kluska from Cantor Fitzgerald set a target price of $105.0 on 09/05/2025
  • Whitney Ijem from Canaccord Genuity set a target price of $128.0 on 08/08/2025
  • Jeffrey Hung from Morgan Stanley set a target price of $55.0 on 07/14/2025
  • Laura Chico from Wedbush set a target price of $34.0 on 07/14/2025
  • Tiago Fauth from Wells Fargo set a target price of $65.0 on 07/10/2025
  • Debjit Chattopadhyay from Guggenheim set a target price of $64.0 on 06/20/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles